204 related articles for article (PubMed ID: 32278658)
1. Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.
Gupta S; Nicassio L; Junquera GY; Jackson AR; Fuchs M; McLeod D; Alpert S; Jayanthi VR; DaJusta D; McHugh KM; Becknell B; Ching CB
J Pediatr Urol; 2020 Oct; 16(5):592.e1-592.e7. PubMed ID: 32278658
[TBL] [Abstract][Full Text] [Related]
2. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
Gupta S; Jackson AR; DaJusta DG; McLeod DJ; Alpert SA; Jayanthi VR; McHugh K; Schwaderer AR; Becknell B; Ching CB
J Pediatr Urol; 2018 Jun; 14(3):238.e1-238.e6. PubMed ID: 29706289
[TBL] [Abstract][Full Text] [Related]
3. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
Cost NG; Noh PH; Devarajan P; Ivancic V; Reddy PP; Minevich E; Bennett M; Haffner C; Schulte M; DeFoor WR
J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
[TBL] [Abstract][Full Text] [Related]
4. Reoperative robotic pyeloplasty in children.
Davis TD; Burns AS; Corbett ST; Peters CA
J Pediatr Urol; 2016 Dec; 12(6):394.e1-394.e7. PubMed ID: 27423387
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.
Gupta S; Preece J; Haynes A; Becknell B; Ching C
Top Spinal Cord Inj Rehabil; 2019; 25(3):214-221. PubMed ID: 31548788
[No Abstract] [Full Text] [Related]
6. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
Yu L; Zhou L; Li Q; Li S; Luo X; Zhang C; Wu B; Brooks JD; Sun H
J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
[TBL] [Abstract][Full Text] [Related]
7. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
[TBL] [Abstract][Full Text] [Related]
8. Hydronephrosis: Comparison of extrinsic vessel versus intrinsic ureteropelvic junction obstruction groups and a plea against the vascular hitch procedure.
Menon P; Rao KL; Sodhi KS; Bhattacharya A; Saxena AK; Mittal BR
J Pediatr Urol; 2015 Apr; 11(2):80.e1-6. PubMed ID: 25794866
[TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic pyeloplasty versus open pyeloplasty for recurrent ureteropelvic junction obstruction in children.
Abdel-Karim AM; Fahmy A; Moussa A; Rashad H; Elbadry M; Badawy H; Hammady A
J Pediatr Urol; 2016 Dec; 12(6):401.e1-401.e6. PubMed ID: 27614698
[TBL] [Abstract][Full Text] [Related]
11. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
Alizadeh F; Taefnia AM; Haghdani S
J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
[TBL] [Abstract][Full Text] [Related]
12. Changes in differential renal function after pyeloplasty in infants and children.
Nordenström J; Koutozi G; Holmdahl G; Abrahamsson K; Sixt R; Sjöström S
J Pediatr Urol; 2020 Jun; 16(3):329.e1-329.e8. PubMed ID: 32146062
[TBL] [Abstract][Full Text] [Related]
13. The role of voiding cystourethrography in asymptomatic unilateral isolated ureteropelvic junction obstruction: A retrospective study.
ElSheemy MS; Ghoneima W; Abdelwahhab M; Aboulela W; Daw K; Shouman AM; Shoukry AI; El Ghoneimy M; Morsi HA; Badawy H
J Pediatr Urol; 2017 Apr; 13(2):206.e1-206.e7. PubMed ID: 27964829
[TBL] [Abstract][Full Text] [Related]
14. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.
Pavlaki A; Printza N; Farmaki E; Stabouli S; Taparkou A; Sterpi M; Dotis J; Papachristou F
Pediatr Nephrol; 2020 Jan; 35(1):163-170. PubMed ID: 31606750
[TBL] [Abstract][Full Text] [Related]
15. A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.
Devarakonda CKV; Shearier ER; Hu C; Grady J; Balsbaugh JL; Makari JH; Ferrer FA; Shapiro LH
J Pediatr Urol; 2020 Aug; 16(4):466.e1-466.e9. PubMed ID: 32620509
[TBL] [Abstract][Full Text] [Related]
16. The morphology and treatment of coexisting ureteropelvic junction obstruction in lower moiety of duplex kidney.
Liu W; Zhang L; Ma R; Wu R
Int J Surg; 2016 Oct; 34():23-27. PubMed ID: 27545957
[TBL] [Abstract][Full Text] [Related]
17. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
Wang HS; Cho PS; Zhi H; Kostel SA; DiMartino S; Dagher AM; Davis KH; Cabour LD; Shimmel A; Lee J; Froehlich JW; Zurakowski D; Moses MA; Lee RS
PLoS One; 2022; 17(7):e0270018. PubMed ID: 35834547
[TBL] [Abstract][Full Text] [Related]
18. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
Assadi F; Mazaheri M
J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
[TBL] [Abstract][Full Text] [Related]
19. Incidence of pathologic postobstructive diuresis after resolution of ureteropelvic junction obstruction with a normal contralateral kidney.
Roth JD; Lesier JD; Casey JT; Szymanski KM; Whittam BM; Misseri R; Rink RC; Cain MP
J Pediatr Urol; 2018 Dec; 14(6):557.e1-557.e6. PubMed ID: 30139574
[TBL] [Abstract][Full Text] [Related]
20. The role of Acucise endopyelotomy in the treatment of ureteropelvic junction obstruction.
Biyani CS; Minhas S; el Cast J; Almond DJ; Cooksey G; Hetherington JW
Eur Urol; 2002 Mar; 41(3):305-10; discussion 310-1. PubMed ID: 12180233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
